In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease
- PMID: 27353586
In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease
Abstract
Background & objectives: NS2B-NS3 protease (NS2B-NS3 pro ) of dengue virus (DENV) is the prime therapeutic target for the development of anti-dengue drug to combat the DENV infection, which is currently an increasing health problem in many countries. In the area of antiviral drug discovery, numerous reports on the antiviral activity of various medicinal plants against dengue viruses have been published. Neem plant (Azadirachta indica) is one among those medicinal plants which is reported to show potential antiviral activity against DENV. But active principle of neem plant extract which has inhibitory potential against DENV NS2B-NS3 pro is not yet reported. The aim of the present study was to explore the inhibitory potential of five triterpenoids from neem plant, viz. nimbin, desacetylnimbin, desacetylsalannin, azadirachtin and salannin, against DENV NS2B-NS3 pro.
Methods: The molecular 3D structural data of DENV NS2B-NS3 pro and selected triterpenoids of neem plant were collected from protein databank (PDB ID: 2VBC) and PubChem database respectively. The molecular docking approach was employed to find out the in silico inhibitory potential of the five triterpenoids against DENV NS2B- NS3 pro.
Results: The molecular docking results showed that nimbin, desacetylnimbin and desacetylsalannin have good binding affinity with DENV NS2B-NS3 pro , while azadirachtin and salannin did not show any interaction with the target protein. It was observed that the DENV NS2B-NS3 pro binding energy for nimbin, desacetylnimbin and desacetylsalannin were -5.56, -5.24 and -3.43 kcal/mol, respectively.
Interpretation & conclusion: The findings attained through this study on the molecular interaction mode of three neem triterpenoids and DENV NS2B-NS3 pro can be considered for further in vitro and in vivo validation for designing new potential drugs for DENV infection.
Similar articles
-
Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease.Sci Rep. 2019 Dec 13;9(1):19059. doi: 10.1038/s41598-019-55723-5. Sci Rep. 2019. PMID: 31836806 Free PMC article.
-
Computer-aided identification of dengue virus NS2B/NS3 protease inhibitors: an integrated molecular modelling approach for screening of phytochemicals.J Biomol Struct Dyn. 2024;42(20):11052-11063. doi: 10.1080/07391102.2023.2259496. Epub 2023 Sep 25. J Biomol Struct Dyn. 2024. PMID: 37747078
-
Discovery of antiviral molecules for dengue: In silico search and biological evaluation.Eur J Med Chem. 2016 Mar 3;110:87-97. doi: 10.1016/j.ejmech.2015.12.030. Epub 2016 Jan 7. Eur J Med Chem. 2016. PMID: 26807547
-
The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection.Int J Mol Sci. 2024 Apr 16;25(8):4376. doi: 10.3390/ijms25084376. Int J Mol Sci. 2024. PMID: 38673962 Free PMC article. Review.
-
West Nile Virus NS2B/NS3 protease as an antiviral target.Curr Med Chem. 2008;15(27):2771-84. doi: 10.2174/092986708786242804. Curr Med Chem. 2008. PMID: 18991636 Review.
Cited by
-
Identification of new potent inhibitors of dengue virus NS3 protease from traditional Chinese medicine database.Virusdisease. 2016 Sep;27(3):220-225. doi: 10.1007/s13337-016-0328-6. Epub 2016 Jul 20. Virusdisease. 2016. PMID: 28466032 Free PMC article.
-
A short survey of dengue protease inhibitor development in the past 6 years (2015-2020) with an emphasis on similarities between DENV and SARS-CoV-2 proteases.Bioorg Med Chem. 2021 Nov 1;49:116415. doi: 10.1016/j.bmc.2021.116415. Epub 2021 Sep 20. Bioorg Med Chem. 2021. PMID: 34601454 Free PMC article. Review.
-
Ethnomedicinal herbs in African traditional medicine with potential activity for the prevention, treatment, and management of coronavirus disease 2019.Futur J Pharm Sci. 2021;7(1):72. doi: 10.1186/s43094-021-00223-5. Epub 2021 Mar 20. Futur J Pharm Sci. 2021. PMID: 33778086 Free PMC article. Review.
-
In vivo evaluation of the antiretroviral activity of Melia azedarach against small ruminant lentiviruses in goat colostrum and milk.Braz J Microbiol. 2024 Mar;55(1):875-887. doi: 10.1007/s42770-023-01174-0. Epub 2023 Nov 27. Braz J Microbiol. 2024. PMID: 38010582 Free PMC article.
-
Phytocompounds as potential inhibitors of mycobacterial multidrug efflux pump Rv1258c: an in silico approach.AMB Express. 2024 Feb 15;14(1):25. doi: 10.1186/s13568-024-01673-9. AMB Express. 2024. PMID: 38360998 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources